Identifying the Most Accurate Method for Predicting the Safe Depth of Orally Placed Neonatal Endotracheal Tubes (ETT).
NCT ID: NCT02181894
Last Updated: 2018-07-26
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
8 participants
OBSERVATIONAL
2014-11-30
2016-07-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The morbidity and the financial impact suggest an optimal and accurate approach to place ETT in neonates has not been identified. Other methods to estimate the proper depth of the orotracheal tube have shown promise yet no comparison studies have been performed. Identifying the most accurate method to safely place neonatal orotracheal tubes will improve placement precision and reduce adverse events and their associated costs.
Hypothesis
Compared to weight, sternal to xyphoid length and shoulder to elbow length, the nasal to tragus length will become the most accurate method for predicting the safe depth of orally placed neonatal endotracheal tubes.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Correct Endotracheal Tube Position in Newborns Intubated in the Delivery Room
NCT03770104
Confirmation of Tube Placement in Newborns
NCT05229887
Performance of Lung Ultrasonography for Endotracheal Tube Positioning in Neonates
NCT03818139
Effects of Two Modalities of Non-invasive Ventilation After Extubation in Very Low Birth Weight Neonates
NCT03551314
Umbilical or Peripheral Catheter Insertion for Preterm Infants on Admission to the NICU
NCT04761484
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Orally intubated infants
Subjects will be \<72 hours of age and orally intubated. Following consent, four measures will be reported (i.e. body weight, nasal to tragus length, suprasternal notch to xyphoid process and shoulder to elbow length). Measures will be compared against a chest x-ray and placement of ETT at the subjects lip to identify the most accurate method to place endotracheal tubes in the newborn.
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Hydrops fetalis
* Thoracic congenital anomalies
* Facial abnormalities
* Naso-tracheal intubation
1 Minute
72 Hours
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Colorado, Denver
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Susan L Moran, DNP APRN NNP-BC FFNMRCSI
Role: PRINCIPAL_INVESTIGATOR
Children's Hospital Colorado
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Kaiser Permanente, Los Angeles Medical Center
Los Angeles, California, United States
Children's Hospital Colorado
Aurora, Colorado, United States
University of Colorado Hospital
Aurora, Colorado, United States
The Coombe Women & Infants University Hospital
Dublin, , Ireland
The Rotunda Hospital
Dublin, , Ireland
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
14-1117
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.